Outcomes of Reduced Elective Nodal Radiation Dose and Volume for Laryngeal, Hypopharyngeal, and p16‐Negative Oropharyngeal Cancers
Head & Neck · 2025
DOI: 10.1002/hed.28217 ↗Kurz gefasst
Fachartikel in der Zeitschrift Head & Neck, 2025. Verfasst von Kaveh Zakeri und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA. Hauptthemen laut MEDLINE: Oropharyngeal Neoplasms, Hypopharyngeal Neoplasms, Neoplasm Recurrence, Local, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Background
Reducing elective nodal irradiation dose can decrease treatment toxicity and improve quality of life for head and neck cancer patients.
Methods
We determined the effectiveness of reducing elective radiotherapy doses to 40 Gy for a consecutive cohort of laryngeal, hypopharyngeal, and p16‐negative oropharyngeal or unknown primary squamous cell carcinomas treated with concurrent chemoradiation. The primary outcome measure was solitary elective nodal recurrence.
Results
The cohort included 73 consecutive patients with a median follow up of 23.3 months. There were no cases of solitary elective nodal recurrence. Six patients had locoregional recurrence, eight had distant recurrence, and two had simultaneous locoregional and distant recurrence. All locoregional recurrences occured in the 70 Gy target volume (three in the primary tumor target, three in the involved node target, and two in both).
Conclusions
Reduction in elective nodal radiation dose did not lead to solitary elective nodal recurrences for laryngeal, hypopharyngeal, and p16‐negative oropharyngeal cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
- Department of Radiation Oncology, Yale University, New Haven, Connecticut, USA.
- Department of Radiation Oncology, University of Toronto, Toronto, Canada.
- Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
- Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
ORCID-Profile: Kaveh Zakeri, Trisha Shang
Förderung
- NCI NIH HHS
Zitieren
APA
Zakeri, K., Wren, S. D., Shang, T., Yu, Y., Chen, L., Shamseddine, A., Safavi, A. H., Kang, J. J., Tsai, C. J., Sherman, E. J., Wong, R. J., McBride, S. M., Gelblum, D., Riaz, N., & Lee, N. Y. (2025). Outcomes of Reduced Elective Nodal Radiation Dose and Volume for Laryngeal, Hypopharyngeal, and p16‐Negative Oropharyngeal Cancers. Head & Neck. https://doi.org/10.1002/hed.28217
Vancouver
Zakeri K, Wren SD, Shang T, Yu Y, Chen L, Shamseddine A, et al. Outcomes of Reduced Elective Nodal Radiation Dose and Volume for Laryngeal, Hypopharyngeal, and p16‐Negative Oropharyngeal Cancers. Head & Neck. 2025. doi:10.1002/hed.28217
BibTeX
@article{Zakeri2025,
author = {Zakeri, Kaveh and Wren, Steven D and Shang, Trisha and Yu, Yao and Chen, Linda and Shamseddine, Achraf and Safavi, Amir H and Kang, Jung Julie and Tsai, C Jillian and Sherman, Eric J and Wong, Richard J and McBride, Sean M and Gelblum, Daphna and Riaz, Nadeem and Lee, Nancy Y},
title = {Outcomes of Reduced Elective Nodal Radiation Dose and Volume for Laryngeal, Hypopharyngeal, and p16‐Negative Oropharyngeal Cancers},
journal = {Head & Neck},
year = {2025},
doi = {10.1002/hed.28217}
}
EUVIMED